Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1476, 2005-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Abciximab invaluable for PCI in CHD in the UK
Inpharma, Vol. 1, Iss. 1371, 2003-01 ,pp. :
Access to resources
Recommend
Abciximab invaluable for PCI in CHD in the UK
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 396, 2003-01 ,pp. :
Abciximab beneficial in younger patients with ACS undergoing PCI
Inpharma, Vol. 1, Iss. 1569, 2007-01 ,pp. :
BRAVE researchers say abciximab of no benefit in PCI for STEMI
Inpharma, Vol. 1, Iss. 1632, 2008-01 ,pp. :
Extra cost of abciximab justified in PCI?
Inpharma, Vol. 1, Iss. 1288, 2001-01 ,pp. :